nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—Eye disorder—Cisplatin—esophageal cancer	0.000876	0.00123	CcSEcCtD
Ropinirole—Tinnitus—Cisplatin—esophageal cancer	0.000874	0.00122	CcSEcCtD
Ropinirole—Lymphadenopathy—Methotrexate—esophageal cancer	0.000872	0.00122	CcSEcCtD
Ropinirole—Flushing—Cisplatin—esophageal cancer	0.00087	0.00122	CcSEcCtD
Ropinirole—Cardiac disorder—Cisplatin—esophageal cancer	0.00087	0.00122	CcSEcCtD
Ropinirole—Abdominal distension—Capecitabine—esophageal cancer	0.000869	0.00122	CcSEcCtD
Ropinirole—Influenza—Capecitabine—esophageal cancer	0.000863	0.00121	CcSEcCtD
Ropinirole—Dysphagia—Capecitabine—esophageal cancer	0.000863	0.00121	CcSEcCtD
Ropinirole—Asthma—Capecitabine—esophageal cancer	0.000863	0.00121	CcSEcCtD
Ropinirole—Thrombophlebitis—Methotrexate—esophageal cancer	0.000859	0.0012	CcSEcCtD
Ropinirole—Diabetes mellitus—Methotrexate—esophageal cancer	0.000855	0.0012	CcSEcCtD
Ropinirole—Polyuria—Methotrexate—esophageal cancer	0.000847	0.00119	CcSEcCtD
Ropinirole—Immune system disorder—Cisplatin—esophageal cancer	0.000847	0.00118	CcSEcCtD
Ropinirole—Mediastinal disorder—Cisplatin—esophageal cancer	0.000845	0.00118	CcSEcCtD
Ropinirole—Angina pectoris—Capecitabine—esophageal cancer	0.000841	0.00118	CcSEcCtD
Ropinirole—Sweating increased—Capecitabine—esophageal cancer	0.000841	0.00118	CcSEcCtD
Ropinirole—Arrhythmia—Cisplatin—esophageal cancer	0.000838	0.00117	CcSEcCtD
Ropinirole—Bronchitis—Capecitabine—esophageal cancer	0.00083	0.00116	CcSEcCtD
Ropinirole—Alopecia—Cisplatin—esophageal cancer	0.000828	0.00116	CcSEcCtD
Ropinirole—Abdominal discomfort—Capecitabine—esophageal cancer	0.000828	0.00116	CcSEcCtD
Ropinirole—Malnutrition—Cisplatin—esophageal cancer	0.000816	0.00114	CcSEcCtD
Ropinirole—Dysuria—Capecitabine—esophageal cancer	0.000807	0.00113	CcSEcCtD
Ropinirole—Renal failure acute—Methotrexate—esophageal cancer	0.000805	0.00113	CcSEcCtD
Ropinirole—Flatulence—Cisplatin—esophageal cancer	0.000804	0.00113	CcSEcCtD
Ropinirole—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000802	0.00112	CcSEcCtD
Ropinirole—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000788	0.0011	CcSEcCtD
Ropinirole—Weight increased—Capecitabine—esophageal cancer	0.000786	0.0011	CcSEcCtD
Ropinirole—Visual disturbance—Methotrexate—esophageal cancer	0.000785	0.0011	CcSEcCtD
Ropinirole—Muscle spasms—Cisplatin—esophageal cancer	0.000785	0.0011	CcSEcCtD
Ropinirole—Weight decreased—Capecitabine—esophageal cancer	0.000781	0.00109	CcSEcCtD
Ropinirole—Hyperglycaemia—Capecitabine—esophageal cancer	0.000779	0.00109	CcSEcCtD
Ropinirole—Pneumonia—Capecitabine—esophageal cancer	0.000774	0.00108	CcSEcCtD
Ropinirole—Infestation NOS—Capecitabine—esophageal cancer	0.00077	0.00108	CcSEcCtD
Ropinirole—Infestation—Capecitabine—esophageal cancer	0.00077	0.00108	CcSEcCtD
Ropinirole—Vision blurred—Cisplatin—esophageal cancer	0.000769	0.00108	CcSEcCtD
Ropinirole—Depression—Capecitabine—esophageal cancer	0.000768	0.00107	CcSEcCtD
Ropinirole—Tremor—Cisplatin—esophageal cancer	0.000765	0.00107	CcSEcCtD
Ropinirole—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000759	0.00106	CcSEcCtD
Ropinirole—Lethargy—Methotrexate—esophageal cancer	0.000759	0.00106	CcSEcCtD
Ropinirole—Ill-defined disorder—Cisplatin—esophageal cancer	0.000757	0.00106	CcSEcCtD
Ropinirole—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000755	0.00106	CcSEcCtD
Ropinirole—Myocardial infarction—Capecitabine—esophageal cancer	0.000755	0.00106	CcSEcCtD
Ropinirole—Anaemia—Cisplatin—esophageal cancer	0.000754	0.00106	CcSEcCtD
Ropinirole—Stomatitis—Capecitabine—esophageal cancer	0.00075	0.00105	CcSEcCtD
Ropinirole—Urinary tract infection—Capecitabine—esophageal cancer	0.000748	0.00105	CcSEcCtD
Ropinirole—Conjunctivitis—Capecitabine—esophageal cancer	0.000748	0.00105	CcSEcCtD
Ropinirole—Osteoarthritis—Methotrexate—esophageal cancer	0.000744	0.00104	CcSEcCtD
Ropinirole—Malaise—Cisplatin—esophageal cancer	0.000736	0.00103	CcSEcCtD
Ropinirole—Haematuria—Capecitabine—esophageal cancer	0.000734	0.00103	CcSEcCtD
Ropinirole—Leukopenia—Cisplatin—esophageal cancer	0.000731	0.00102	CcSEcCtD
Ropinirole—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000728	0.00102	CcSEcCtD
Ropinirole—Epistaxis—Capecitabine—esophageal cancer	0.000726	0.00102	CcSEcCtD
Ropinirole—Agranulocytosis—Capecitabine—esophageal cancer	0.000718	0.00101	CcSEcCtD
Ropinirole—Irritability—Methotrexate—esophageal cancer	0.00071	0.000993	CcSEcCtD
Ropinirole—Convulsion—Cisplatin—esophageal cancer	0.000707	0.000989	CcSEcCtD
Ropinirole—Mood swings—Methotrexate—esophageal cancer	0.000704	0.000986	CcSEcCtD
Ropinirole—Bradycardia—Capecitabine—esophageal cancer	0.000704	0.000984	CcSEcCtD
Ropinirole—Ataxia—Methotrexate—esophageal cancer	0.000699	0.000978	CcSEcCtD
Ropinirole—Myalgia—Cisplatin—esophageal cancer	0.000695	0.000972	CcSEcCtD
Ropinirole—Haemoglobin—Capecitabine—esophageal cancer	0.000695	0.000972	CcSEcCtD
Ropinirole—Rhinitis—Capecitabine—esophageal cancer	0.000693	0.000969	CcSEcCtD
Ropinirole—Anxiety—Cisplatin—esophageal cancer	0.000692	0.000969	CcSEcCtD
Ropinirole—Haemorrhage—Capecitabine—esophageal cancer	0.000691	0.000967	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00069	0.000966	CcSEcCtD
Ropinirole—Hypoaesthesia—Capecitabine—esophageal cancer	0.000688	0.000962	CcSEcCtD
Ropinirole—Discomfort—Cisplatin—esophageal cancer	0.000686	0.000961	CcSEcCtD
Ropinirole—Pharyngitis—Capecitabine—esophageal cancer	0.000686	0.00096	CcSEcCtD
Ropinirole—Urinary tract disorder—Capecitabine—esophageal cancer	0.000682	0.000955	CcSEcCtD
Ropinirole—Oedema peripheral—Capecitabine—esophageal cancer	0.000681	0.000953	CcSEcCtD
Ropinirole—Connective tissue disorder—Capecitabine—esophageal cancer	0.000679	0.00095	CcSEcCtD
Ropinirole—Urethral disorder—Capecitabine—esophageal cancer	0.000677	0.000948	CcSEcCtD
Ropinirole—Breast disorder—Methotrexate—esophageal cancer	0.000672	0.00094	CcSEcCtD
Ropinirole—Oedema—Cisplatin—esophageal cancer	0.000666	0.000932	CcSEcCtD
Ropinirole—Visual impairment—Capecitabine—esophageal cancer	0.000666	0.000932	CcSEcCtD
Ropinirole—Infection—Cisplatin—esophageal cancer	0.000662	0.000926	CcSEcCtD
Ropinirole—Nervous system disorder—Cisplatin—esophageal cancer	0.000653	0.000914	CcSEcCtD
Ropinirole—Thrombocytopenia—Cisplatin—esophageal cancer	0.000652	0.000913	CcSEcCtD
Ropinirole—Tachycardia—Cisplatin—esophageal cancer	0.00065	0.00091	CcSEcCtD
Ropinirole—Skin disorder—Cisplatin—esophageal cancer	0.000647	0.000905	CcSEcCtD
Ropinirole—Eye disorder—Capecitabine—esophageal cancer	0.000646	0.000904	CcSEcCtD
Ropinirole—Tinnitus—Capecitabine—esophageal cancer	0.000644	0.000902	CcSEcCtD
Ropinirole—Hyperhidrosis—Cisplatin—esophageal cancer	0.000644	0.000901	CcSEcCtD
Ropinirole—Asthma—Methotrexate—esophageal cancer	0.000643	0.000899	CcSEcCtD
Ropinirole—Cardiac disorder—Capecitabine—esophageal cancer	0.000641	0.000897	CcSEcCtD
Ropinirole—Flushing—Capecitabine—esophageal cancer	0.000641	0.000897	CcSEcCtD
Ropinirole—Eosinophilia—Methotrexate—esophageal cancer	0.000636	0.00089	CcSEcCtD
Ropinirole—Anorexia—Cisplatin—esophageal cancer	0.000635	0.000888	CcSEcCtD
Ropinirole—Pancreatitis—Methotrexate—esophageal cancer	0.00063	0.000882	CcSEcCtD
Ropinirole—Angiopathy—Capecitabine—esophageal cancer	0.000627	0.000877	CcSEcCtD
Ropinirole—Immune system disorder—Capecitabine—esophageal cancer	0.000624	0.000873	CcSEcCtD
Ropinirole—Mediastinal disorder—Capecitabine—esophageal cancer	0.000623	0.000872	CcSEcCtD
Ropinirole—Hypotension—Cisplatin—esophageal cancer	0.000622	0.000871	CcSEcCtD
Ropinirole—Chills—Capecitabine—esophageal cancer	0.00062	0.000868	CcSEcCtD
Ropinirole—Arrhythmia—Capecitabine—esophageal cancer	0.000617	0.000864	CcSEcCtD
Ropinirole—Abdominal discomfort—Methotrexate—esophageal cancer	0.000616	0.000862	CcSEcCtD
Ropinirole—Alopecia—Capecitabine—esophageal cancer	0.000611	0.000855	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000607	0.000849	CcSEcCtD
Ropinirole—Mental disorder—Capecitabine—esophageal cancer	0.000605	0.000847	CcSEcCtD
Ropinirole—Malnutrition—Capecitabine—esophageal cancer	0.000602	0.000842	CcSEcCtD
Ropinirole—Dysuria—Methotrexate—esophageal cancer	0.000601	0.000841	CcSEcCtD
Ropinirole—Paraesthesia—Cisplatin—esophageal cancer	0.000598	0.000837	CcSEcCtD
Ropinirole—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000597	0.000836	CcSEcCtD
Ropinirole—Dyspnoea—Cisplatin—esophageal cancer	0.000594	0.000831	CcSEcCtD
Ropinirole—Flatulence—Capecitabine—esophageal cancer	0.000593	0.000829	CcSEcCtD
Ropinirole—Erectile dysfunction—Methotrexate—esophageal cancer	0.000592	0.000828	CcSEcCtD
Ropinirole—Dysgeusia—Capecitabine—esophageal cancer	0.000589	0.000824	CcSEcCtD
Ropinirole—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000587	0.000821	CcSEcCtD
Ropinirole—Back pain—Capecitabine—esophageal cancer	0.000582	0.000814	CcSEcCtD
Ropinirole—Decreased appetite—Cisplatin—esophageal cancer	0.000579	0.00081	CcSEcCtD
Ropinirole—Muscle spasms—Capecitabine—esophageal cancer	0.000578	0.000809	CcSEcCtD
Ropinirole—Pneumonia—Methotrexate—esophageal cancer	0.000576	0.000807	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000575	0.000805	CcSEcCtD
Ropinirole—Infestation NOS—Methotrexate—esophageal cancer	0.000573	0.000802	CcSEcCtD
Ropinirole—Infestation—Methotrexate—esophageal cancer	0.000573	0.000802	CcSEcCtD
Ropinirole—Depression—Methotrexate—esophageal cancer	0.000571	0.0008	CcSEcCtD
Ropinirole—Pain—Cisplatin—esophageal cancer	0.00057	0.000797	CcSEcCtD
Ropinirole—Vision blurred—Capecitabine—esophageal cancer	0.000567	0.000793	CcSEcCtD
Ropinirole—Tremor—Capecitabine—esophageal cancer	0.000564	0.000789	CcSEcCtD
Ropinirole—Stomatitis—Methotrexate—esophageal cancer	0.000559	0.000782	CcSEcCtD
Ropinirole—Ill-defined disorder—Capecitabine—esophageal cancer	0.000558	0.000781	CcSEcCtD
Ropinirole—Conjunctivitis—Methotrexate—esophageal cancer	0.000557	0.000779	CcSEcCtD
Ropinirole—Anaemia—Capecitabine—esophageal cancer	0.000556	0.000778	CcSEcCtD
Ropinirole—Feeling abnormal—Cisplatin—esophageal cancer	0.000549	0.000768	CcSEcCtD
Ropinirole—Haematuria—Methotrexate—esophageal cancer	0.000546	0.000765	CcSEcCtD
Ropinirole—Malaise—Capecitabine—esophageal cancer	0.000543	0.000759	CcSEcCtD
Ropinirole—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000542	0.000758	CcSEcCtD
Ropinirole—Epistaxis—Methotrexate—esophageal cancer	0.000541	0.000756	CcSEcCtD
Ropinirole—Vertigo—Capecitabine—esophageal cancer	0.00054	0.000756	CcSEcCtD
Ropinirole—Syncope—Capecitabine—esophageal cancer	0.000539	0.000755	CcSEcCtD
Ropinirole—Leukopenia—Capecitabine—esophageal cancer	0.000538	0.000754	CcSEcCtD
Ropinirole—Agranulocytosis—Methotrexate—esophageal cancer	0.000535	0.000748	CcSEcCtD
Ropinirole—Palpitations—Capecitabine—esophageal cancer	0.000532	0.000744	CcSEcCtD
Ropinirole—Loss of consciousness—Capecitabine—esophageal cancer	0.000529	0.00074	CcSEcCtD
Ropinirole—Body temperature increased—Cisplatin—esophageal cancer	0.000527	0.000737	CcSEcCtD
Ropinirole—Cough—Capecitabine—esophageal cancer	0.000525	0.000735	CcSEcCtD
Ropinirole—Hypertension—Capecitabine—esophageal cancer	0.000519	0.000727	CcSEcCtD
Ropinirole—Haemoglobin—Methotrexate—esophageal cancer	0.000517	0.000724	CcSEcCtD
Ropinirole—Haemorrhage—Methotrexate—esophageal cancer	0.000514	0.00072	CcSEcCtD
Ropinirole—Chest pain—Capecitabine—esophageal cancer	0.000512	0.000717	CcSEcCtD
Ropinirole—Myalgia—Capecitabine—esophageal cancer	0.000512	0.000717	CcSEcCtD
Ropinirole—Arthralgia—Capecitabine—esophageal cancer	0.000512	0.000717	CcSEcCtD
Ropinirole—Pharyngitis—Methotrexate—esophageal cancer	0.000511	0.000714	CcSEcCtD
Ropinirole—Anxiety—Capecitabine—esophageal cancer	0.00051	0.000714	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000509	0.000712	CcSEcCtD
Ropinirole—Urinary tract disorder—Methotrexate—esophageal cancer	0.000508	0.000711	CcSEcCtD
Ropinirole—Discomfort—Capecitabine—esophageal cancer	0.000506	0.000708	CcSEcCtD
Ropinirole—Urethral disorder—Methotrexate—esophageal cancer	0.000504	0.000706	CcSEcCtD
Ropinirole—Dry mouth—Capecitabine—esophageal cancer	0.000501	0.000701	CcSEcCtD
Ropinirole—Visual impairment—Methotrexate—esophageal cancer	0.000496	0.000694	CcSEcCtD
Ropinirole—Confusional state—Capecitabine—esophageal cancer	0.000495	0.000693	CcSEcCtD
Ropinirole—Oedema—Capecitabine—esophageal cancer	0.000491	0.000687	CcSEcCtD
Ropinirole—Hypersensitivity—Cisplatin—esophageal cancer	0.000491	0.000687	CcSEcCtD
Ropinirole—Infection—Capecitabine—esophageal cancer	0.000488	0.000683	CcSEcCtD
Ropinirole—Shock—Capecitabine—esophageal cancer	0.000483	0.000676	CcSEcCtD
Ropinirole—Nervous system disorder—Capecitabine—esophageal cancer	0.000481	0.000674	CcSEcCtD
Ropinirole—Eye disorder—Methotrexate—esophageal cancer	0.000481	0.000673	CcSEcCtD
Ropinirole—Thrombocytopenia—Capecitabine—esophageal cancer	0.000481	0.000673	CcSEcCtD
Ropinirole—Tinnitus—Methotrexate—esophageal cancer	0.00048	0.000671	CcSEcCtD
Ropinirole—Tachycardia—Capecitabine—esophageal cancer	0.000479	0.000671	CcSEcCtD
Ropinirole—Asthenia—Cisplatin—esophageal cancer	0.000478	0.000669	CcSEcCtD
Ropinirole—Cardiac disorder—Methotrexate—esophageal cancer	0.000477	0.000668	CcSEcCtD
Ropinirole—Skin disorder—Capecitabine—esophageal cancer	0.000477	0.000667	CcSEcCtD
Ropinirole—Hyperhidrosis—Capecitabine—esophageal cancer	0.000475	0.000664	CcSEcCtD
Ropinirole—Anorexia—Capecitabine—esophageal cancer	0.000468	0.000655	CcSEcCtD
Ropinirole—Angiopathy—Methotrexate—esophageal cancer	0.000467	0.000653	CcSEcCtD
Ropinirole—Immune system disorder—Methotrexate—esophageal cancer	0.000465	0.00065	CcSEcCtD
Ropinirole—Mediastinal disorder—Methotrexate—esophageal cancer	0.000464	0.000649	CcSEcCtD
Ropinirole—Chills—Methotrexate—esophageal cancer	0.000462	0.000646	CcSEcCtD
Ropinirole—Hypotension—Capecitabine—esophageal cancer	0.000459	0.000642	CcSEcCtD
Ropinirole—Diarrhoea—Cisplatin—esophageal cancer	0.000456	0.000638	CcSEcCtD
Ropinirole—Alopecia—Methotrexate—esophageal cancer	0.000455	0.000636	CcSEcCtD
Ropinirole—Mental disorder—Methotrexate—esophageal cancer	0.000451	0.000631	CcSEcCtD
Ropinirole—Malnutrition—Methotrexate—esophageal cancer	0.000448	0.000627	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000447	0.000626	CcSEcCtD
Ropinirole—Insomnia—Capecitabine—esophageal cancer	0.000444	0.000621	CcSEcCtD
Ropinirole—Paraesthesia—Capecitabine—esophageal cancer	0.000441	0.000617	CcSEcCtD
Ropinirole—Dysgeusia—Methotrexate—esophageal cancer	0.000439	0.000614	CcSEcCtD
Ropinirole—Dyspnoea—Capecitabine—esophageal cancer	0.000438	0.000612	CcSEcCtD
Ropinirole—Back pain—Methotrexate—esophageal cancer	0.000433	0.000606	CcSEcCtD
Ropinirole—Dyspepsia—Capecitabine—esophageal cancer	0.000432	0.000605	CcSEcCtD
Ropinirole—Decreased appetite—Capecitabine—esophageal cancer	0.000427	0.000597	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000424	0.000593	CcSEcCtD
Ropinirole—Vomiting—Cisplatin—esophageal cancer	0.000423	0.000593	CcSEcCtD
Ropinirole—Fatigue—Capecitabine—esophageal cancer	0.000423	0.000592	CcSEcCtD
Ropinirole—Vision blurred—Methotrexate—esophageal cancer	0.000422	0.000591	CcSEcCtD
Ropinirole—Rash—Cisplatin—esophageal cancer	0.00042	0.000588	CcSEcCtD
Ropinirole—Pain—Capecitabine—esophageal cancer	0.00042	0.000587	CcSEcCtD
Ropinirole—Constipation—Capecitabine—esophageal cancer	0.00042	0.000587	CcSEcCtD
Ropinirole—Dermatitis—Cisplatin—esophageal cancer	0.00042	0.000587	CcSEcCtD
Ropinirole—Ill-defined disorder—Methotrexate—esophageal cancer	0.000416	0.000581	CcSEcCtD
Ropinirole—Anaemia—Methotrexate—esophageal cancer	0.000414	0.000579	CcSEcCtD
Ropinirole—Feeling abnormal—Capecitabine—esophageal cancer	0.000405	0.000566	CcSEcCtD
Ropinirole—Malaise—Methotrexate—esophageal cancer	0.000404	0.000565	CcSEcCtD
Ropinirole—Vertigo—Methotrexate—esophageal cancer	0.000402	0.000563	CcSEcCtD
Ropinirole—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000401	0.000562	CcSEcCtD
Ropinirole—Leukopenia—Methotrexate—esophageal cancer	0.000401	0.000561	CcSEcCtD
Ropinirole—Nausea—Cisplatin—esophageal cancer	0.000396	0.000554	CcSEcCtD
Ropinirole—Cough—Methotrexate—esophageal cancer	0.000391	0.000547	CcSEcCtD
Ropinirole—Urticaria—Capecitabine—esophageal cancer	0.00039	0.000546	CcSEcCtD
Ropinirole—Body temperature increased—Capecitabine—esophageal cancer	0.000388	0.000543	CcSEcCtD
Ropinirole—Abdominal pain—Capecitabine—esophageal cancer	0.000388	0.000543	CcSEcCtD
Ropinirole—Convulsion—Methotrexate—esophageal cancer	0.000388	0.000543	CcSEcCtD
Ropinirole—Chest pain—Methotrexate—esophageal cancer	0.000381	0.000534	CcSEcCtD
Ropinirole—Arthralgia—Methotrexate—esophageal cancer	0.000381	0.000534	CcSEcCtD
Ropinirole—Myalgia—Methotrexate—esophageal cancer	0.000381	0.000534	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000379	0.00053	CcSEcCtD
Ropinirole—Discomfort—Methotrexate—esophageal cancer	0.000377	0.000527	CcSEcCtD
Ropinirole—Confusional state—Methotrexate—esophageal cancer	0.000369	0.000516	CcSEcCtD
Ropinirole—Infection—Methotrexate—esophageal cancer	0.000363	0.000508	CcSEcCtD
Ropinirole—Hypersensitivity—Capecitabine—esophageal cancer	0.000362	0.000506	CcSEcCtD
Ropinirole—Nervous system disorder—Methotrexate—esophageal cancer	0.000358	0.000502	CcSEcCtD
Ropinirole—Thrombocytopenia—Methotrexate—esophageal cancer	0.000358	0.000501	CcSEcCtD
Ropinirole—Skin disorder—Methotrexate—esophageal cancer	0.000355	0.000497	CcSEcCtD
Ropinirole—Hyperhidrosis—Methotrexate—esophageal cancer	0.000353	0.000494	CcSEcCtD
Ropinirole—Asthenia—Capecitabine—esophageal cancer	0.000352	0.000493	CcSEcCtD
Ropinirole—Anorexia—Methotrexate—esophageal cancer	0.000348	0.000488	CcSEcCtD
Ropinirole—Pruritus—Capecitabine—esophageal cancer	0.000347	0.000486	CcSEcCtD
Ropinirole—Hypotension—Methotrexate—esophageal cancer	0.000342	0.000478	CcSEcCtD
Ropinirole—Diarrhoea—Capecitabine—esophageal cancer	0.000336	0.00047	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000333	0.000466	CcSEcCtD
Ropinirole—Insomnia—Methotrexate—esophageal cancer	0.000331	0.000463	CcSEcCtD
Ropinirole—Paraesthesia—Methotrexate—esophageal cancer	0.000328	0.000459	CcSEcCtD
Ropinirole—Dyspnoea—Methotrexate—esophageal cancer	0.000326	0.000456	CcSEcCtD
Ropinirole—Somnolence—Methotrexate—esophageal cancer	0.000325	0.000455	CcSEcCtD
Ropinirole—Dizziness—Capecitabine—esophageal cancer	0.000325	0.000454	CcSEcCtD
Ropinirole—Dyspepsia—Methotrexate—esophageal cancer	0.000322	0.00045	CcSEcCtD
Ropinirole—Decreased appetite—Methotrexate—esophageal cancer	0.000318	0.000445	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000316	0.000442	CcSEcCtD
Ropinirole—Fatigue—Methotrexate—esophageal cancer	0.000315	0.000441	CcSEcCtD
Ropinirole—Pain—Methotrexate—esophageal cancer	0.000313	0.000437	CcSEcCtD
Ropinirole—Vomiting—Capecitabine—esophageal cancer	0.000312	0.000437	CcSEcCtD
Ropinirole—Rash—Capecitabine—esophageal cancer	0.00031	0.000433	CcSEcCtD
Ropinirole—Dermatitis—Capecitabine—esophageal cancer	0.000309	0.000433	CcSEcCtD
Ropinirole—Headache—Capecitabine—esophageal cancer	0.000308	0.00043	CcSEcCtD
Ropinirole—Feeling abnormal—Methotrexate—esophageal cancer	0.000301	0.000421	CcSEcCtD
Ropinirole—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000299	0.000418	CcSEcCtD
Ropinirole—Nausea—Capecitabine—esophageal cancer	0.000292	0.000408	CcSEcCtD
Ropinirole—Urticaria—Methotrexate—esophageal cancer	0.00029	0.000406	CcSEcCtD
Ropinirole—Abdominal pain—Methotrexate—esophageal cancer	0.000289	0.000404	CcSEcCtD
Ropinirole—Body temperature increased—Methotrexate—esophageal cancer	0.000289	0.000404	CcSEcCtD
Ropinirole—Hypersensitivity—Methotrexate—esophageal cancer	0.000269	0.000377	CcSEcCtD
Ropinirole—Asthenia—Methotrexate—esophageal cancer	0.000262	0.000367	CcSEcCtD
Ropinirole—Pruritus—Methotrexate—esophageal cancer	0.000259	0.000362	CcSEcCtD
Ropinirole—Diarrhoea—Methotrexate—esophageal cancer	0.00025	0.00035	CcSEcCtD
Ropinirole—Dizziness—Methotrexate—esophageal cancer	0.000242	0.000338	CcSEcCtD
Ropinirole—Vomiting—Methotrexate—esophageal cancer	0.000232	0.000325	CcSEcCtD
Ropinirole—Rash—Methotrexate—esophageal cancer	0.00023	0.000322	CcSEcCtD
Ropinirole—Dermatitis—Methotrexate—esophageal cancer	0.00023	0.000322	CcSEcCtD
Ropinirole—Headache—Methotrexate—esophageal cancer	0.000229	0.00032	CcSEcCtD
Ropinirole—Nausea—Methotrexate—esophageal cancer	0.000217	0.000304	CcSEcCtD
Ropinirole—HTR2B—Signaling Pathways—CREBBP—esophageal cancer	3.38e-05	0.000118	CbGpPWpGaD
Ropinirole—HTR1B—GPCR downstream signaling—PIK3CA—esophageal cancer	3.38e-05	0.000118	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—HIF1A—esophageal cancer	3.35e-05	0.000118	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—HIF1A—esophageal cancer	3.34e-05	0.000117	CbGpPWpGaD
Ropinirole—DRD4—GPCR downstream signaling—PIK3CA—esophageal cancer	3.32e-05	0.000116	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—KDR—esophageal cancer	3.32e-05	0.000116	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—EGFR—esophageal cancer	3.32e-05	0.000116	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—NOS3—esophageal cancer	3.29e-05	0.000115	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—EP300—esophageal cancer	3.27e-05	0.000114	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—HIF1A—esophageal cancer	3.25e-05	0.000114	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GSTT1—esophageal cancer	3.24e-05	0.000114	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—TPI1—esophageal cancer	3.23e-05	0.000113	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTO1—esophageal cancer	3.23e-05	0.000113	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—SMAD4—esophageal cancer	3.22e-05	0.000113	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—NOS3—esophageal cancer	3.22e-05	0.000113	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—KDR—esophageal cancer	3.21e-05	0.000112	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CYP2A6—esophageal cancer	3.2e-05	0.000112	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—PIK3CA—esophageal cancer	3.2e-05	0.000112	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.19e-05	0.000112	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—KDR—esophageal cancer	3.19e-05	0.000112	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CREBBP—esophageal cancer	3.19e-05	0.000112	CbGpPWpGaD
Ropinirole—HTR2B—GPCR downstream signaling—PIK3CA—esophageal cancer	3.17e-05	0.000111	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—CREBBP—esophageal cancer	3.17e-05	0.000111	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—NOS3—esophageal cancer	3.17e-05	0.000111	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CREBBP—esophageal cancer	3.14e-05	0.00011	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—PIK3CA—esophageal cancer	3.13e-05	0.00011	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—EGFR—esophageal cancer	3.13e-05	0.00011	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—NOTCH1—esophageal cancer	3.13e-05	0.00011	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—KDR—esophageal cancer	3.1e-05	0.000109	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—TP53—esophageal cancer	3.1e-05	0.000108	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ALDOB—esophageal cancer	3.09e-05	0.000108	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—EGFR—esophageal cancer	3.09e-05	0.000108	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—ERBB2—esophageal cancer	3.08e-05	0.000108	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—PIK3CA—esophageal cancer	3.07e-05	0.000107	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CYP1B1—esophageal cancer	3.05e-05	0.000107	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ENO1—esophageal cancer	3.04e-05	0.000106	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTGS1—esophageal cancer	3.04e-05	0.000106	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—NOS3—esophageal cancer	3.02e-05	0.000106	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—NOTCH1—esophageal cancer	3.02e-05	0.000106	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—PIK3CA—esophageal cancer	3.02e-05	0.000106	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—ERBB2—esophageal cancer	3.01e-05	0.000106	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—NOTCH1—esophageal cancer	3.01e-05	0.000105	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PSME2—esophageal cancer	2.99e-05	0.000105	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PSME1—esophageal cancer	2.99e-05	0.000105	CbGpPWpGaD
Ropinirole—DRD1—GPCR downstream signaling—PIK3CA—esophageal cancer	2.99e-05	0.000105	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.98e-05	0.000104	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—ERBB2—esophageal cancer	2.96e-05	0.000104	CbGpPWpGaD
Ropinirole—DRD3—GPCR downstream signaling—PIK3CA—esophageal cancer	2.95e-05	0.000103	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.95e-05	0.000103	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—HIF1A—esophageal cancer	2.94e-05	0.000103	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—NOTCH1—esophageal cancer	2.92e-05	0.000102	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—HIF1A—esophageal cancer	2.9e-05	0.000102	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—PIK3CA—esophageal cancer	2.88e-05	0.000101	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CYP19A1—esophageal cancer	2.87e-05	0.0001	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—NOS3—esophageal cancer	2.85e-05	0.0001	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—MYC—esophageal cancer	2.85e-05	9.97e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—NOS3—esophageal cancer	2.84e-05	9.95e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CREBBP—esophageal cancer	2.84e-05	9.94e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—ERBB2—esophageal cancer	2.83e-05	9.91e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—KDR—esophageal cancer	2.82e-05	9.87e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—NOS3—esophageal cancer	2.81e-05	9.86e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GNG7—esophageal cancer	2.81e-05	9.84e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—EGFR—esophageal cancer	2.79e-05	9.77e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—EGFR—esophageal cancer	2.78e-05	9.75e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—KDR—esophageal cancer	2.77e-05	9.71e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CREBBP—esophageal cancer	2.74e-05	9.6e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CREBBP—esophageal cancer	2.73e-05	9.55e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—CCND1—esophageal cancer	2.72e-05	9.52e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—PIK3CA—esophageal cancer	2.72e-05	9.52e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—EGFR—esophageal cancer	2.69e-05	9.43e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—PIK3CA—esophageal cancer	2.68e-05	9.39e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—EGFR—esophageal cancer	2.68e-05	9.38e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—ERBB2—esophageal cancer	2.67e-05	9.35e-05	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—PIK3CA—esophageal cancer	2.67e-05	9.34e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—CCND1—esophageal cancer	2.66e-05	9.32e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—NOTCH1—esophageal cancer	2.65e-05	9.3e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CREBBP—esophageal cancer	2.65e-05	9.29e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—HIF1A—esophageal cancer	2.64e-05	9.24e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—ERBB2—esophageal cancer	2.63e-05	9.22e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.63e-05	9.22e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—CDKN1A—esophageal cancer	2.63e-05	9.21e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—CCND1—esophageal cancer	2.62e-05	9.18e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—HMOX1—esophageal cancer	2.62e-05	9.17e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.61e-05	9.16e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—NOTCH1—esophageal cancer	2.61e-05	9.15e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—EGFR—esophageal cancer	2.6e-05	9.13e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PTGS2—esophageal cancer	2.6e-05	9.1e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CYP1B1—esophageal cancer	2.58e-05	9.05e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—CREBBP—esophageal cancer	2.57e-05	9.02e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—CDKN1A—esophageal cancer	2.57e-05	9.02e-05	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—PIK3CA—esophageal cancer	2.57e-05	9.02e-05	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—PIK3CA—esophageal cancer	2.56e-05	8.97e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—NOS3—esophageal cancer	2.54e-05	8.9e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—CDKN1A—esophageal cancer	2.53e-05	8.88e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—KDR—esophageal cancer	2.52e-05	8.83e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ABCB1—esophageal cancer	2.51e-05	8.8e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTT1—esophageal cancer	2.5e-05	8.77e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—EP300—esophageal cancer	2.5e-05	8.77e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CCND1—esophageal cancer	2.5e-05	8.76e-05	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—PIK3CA—esophageal cancer	2.49e-05	8.72e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP2A6—esophageal cancer	2.47e-05	8.67e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—NOS3—esophageal cancer	2.45e-05	8.6e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—EP300—esophageal cancer	2.45e-05	8.58e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—NOS3—esophageal cancer	2.44e-05	8.55e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CYP19A1—esophageal cancer	2.43e-05	8.51e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—PIK3CA—esophageal cancer	2.42e-05	8.48e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CDKN1A—esophageal cancer	2.42e-05	8.47e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—PIK3CA—esophageal cancer	2.42e-05	8.47e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—EP300—esophageal cancer	2.41e-05	8.45e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CREBBP—esophageal cancer	2.41e-05	8.43e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—ERBB2—esophageal cancer	2.38e-05	8.33e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NOTCH1—esophageal cancer	2.37e-05	8.32e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—NOS3—esophageal cancer	2.37e-05	8.32e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CREBBP—esophageal cancer	2.37e-05	8.29e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—EGFR—esophageal cancer	2.36e-05	8.28e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CCND1—esophageal cancer	2.36e-05	8.26e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTGS1—esophageal cancer	2.34e-05	8.22e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ENO1—esophageal cancer	2.34e-05	8.22e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—TP53—esophageal cancer	2.34e-05	8.19e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—PIK3CA—esophageal cancer	2.34e-05	8.19e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CCND1—esophageal cancer	2.33e-05	8.15e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—EGFR—esophageal cancer	2.33e-05	8.15e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—PIK3CA—esophageal cancer	2.32e-05	8.15e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PSME1—esophageal cancer	2.31e-05	8.09e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PSME2—esophageal cancer	2.31e-05	8.09e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—NOS3—esophageal cancer	2.31e-05	8.08e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—EP300—esophageal cancer	2.3e-05	8.06e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—ERBB2—esophageal cancer	2.29e-05	8.04e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—ERBB2—esophageal cancer	2.28e-05	8e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CDKN1A—esophageal cancer	2.28e-05	7.99e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—PIK3CA—esophageal cancer	2.26e-05	7.92e-05	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—PIK3CA—esophageal cancer	2.26e-05	7.92e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CDKN1A—esophageal cancer	2.25e-05	7.88e-05	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—PIK3CA—esophageal cancer	2.22e-05	7.79e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—ERBB2—esophageal cancer	2.22e-05	7.78e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—HMOX1—esophageal cancer	2.22e-05	7.77e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—MYC—esophageal cancer	2.18e-05	7.64e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.17e-05	7.62e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—EP300—esophageal cancer	2.17e-05	7.6e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—EP300—esophageal cancer	2.16e-05	7.57e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—NOS3—esophageal cancer	2.15e-05	7.55e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CREBBP—esophageal cancer	2.15e-05	7.55e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—EP300—esophageal cancer	2.14e-05	7.5e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MYC—esophageal cancer	2.13e-05	7.48e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—EGFR—esophageal cancer	2.13e-05	7.47e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ABCB1—esophageal cancer	2.13e-05	7.45e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—NOS3—esophageal cancer	2.12e-05	7.43e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—EGFR—esophageal cancer	2.12e-05	7.41e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PTGS2—esophageal cancer	2.11e-05	7.39e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MYC—esophageal cancer	2.1e-05	7.36e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CCND1—esophageal cancer	2.1e-05	7.36e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—EGFR—esophageal cancer	2.09e-05	7.32e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—EGFR—esophageal cancer	2.05e-05	7.2e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—PIK3CA—esophageal cancer	2.05e-05	7.19e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CDKN1A—esophageal cancer	2.03e-05	7.12e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CCND1—esophageal cancer	2.03e-05	7.1e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	2.02e-05	7.09e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—PIK3CA—esophageal cancer	2.02e-05	7.07e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CCND1—esophageal cancer	2.02e-05	7.07e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—ERBB2—esophageal cancer	2.01e-05	7.06e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MYC—esophageal cancer	2e-05	7.03e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.99e-05	6.99e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—ERBB2—esophageal cancer	1.98e-05	6.95e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CCND1—esophageal cancer	1.96e-05	6.87e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—EGFR—esophageal cancer	1.96e-05	6.87e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CDKN1A—esophageal cancer	1.96e-05	6.87e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CDKN1A—esophageal cancer	1.95e-05	6.84e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—EP300—esophageal cancer	1.93e-05	6.77e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NOS3—esophageal cancer	1.93e-05	6.76e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CDKN1A—esophageal cancer	1.9e-05	6.65e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MYC—esophageal cancer	1.89e-05	6.63e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.87e-05	6.57e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—EP300—esophageal cancer	1.87e-05	6.54e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MYC—esophageal cancer	1.87e-05	6.54e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—EP300—esophageal cancer	1.86e-05	6.5e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—PIK3CA—esophageal cancer	1.85e-05	6.48e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—EGFR—esophageal cancer	1.85e-05	6.48e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—PIK3CA—esophageal cancer	1.84e-05	6.44e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—EGFR—esophageal cancer	1.82e-05	6.39e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—PIK3CA—esophageal cancer	1.81e-05	6.35e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—EP300—esophageal cancer	1.81e-05	6.33e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—ERBB2—esophageal cancer	1.8e-05	6.32e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TP53—esophageal cancer	1.79e-05	6.27e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—PIK3CA—esophageal cancer	1.78e-05	6.25e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCND1—esophageal cancer	1.78e-05	6.24e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—EP300—esophageal cancer	1.75e-05	6.15e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TP53—esophageal cancer	1.75e-05	6.14e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCND1—esophageal cancer	1.75e-05	6.14e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TP53—esophageal cancer	1.72e-05	6.04e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CDKN1A—esophageal cancer	1.72e-05	6.03e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.71e-05	5.99e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—PIK3CA—esophageal cancer	1.7e-05	5.96e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CDKN1A—esophageal cancer	1.69e-05	5.94e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MYC—esophageal cancer	1.68e-05	5.9e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CREBBP—esophageal cancer	1.68e-05	5.88e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—EGFR—esophageal cancer	1.65e-05	5.77e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TP53—esophageal cancer	1.65e-05	5.77e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.64e-05	5.75e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—EP300—esophageal cancer	1.64e-05	5.74e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MYC—esophageal cancer	1.63e-05	5.7e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MYC—esophageal cancer	1.62e-05	5.67e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—EP300—esophageal cancer	1.61e-05	5.65e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.61e-05	5.64e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—PIK3CA—esophageal cancer	1.6e-05	5.62e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PIK3CA—esophageal cancer	1.6e-05	5.6e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCND1—esophageal cancer	1.59e-05	5.58e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—EGFR—esophageal cancer	1.59e-05	5.57e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—PIK3CA—esophageal cancer	1.58e-05	5.55e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—EGFR—esophageal cancer	1.58e-05	5.54e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MYC—esophageal cancer	1.57e-05	5.51e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TP53—esophageal cancer	1.55e-05	5.44e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CDKN1A—esophageal cancer	1.54e-05	5.4e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—EGFR—esophageal cancer	1.54e-05	5.39e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TP53—esophageal cancer	1.53e-05	5.37e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—NOS3—esophageal cancer	1.5e-05	5.26e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—EP300—esophageal cancer	1.47e-05	5.14e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PIK3CA—esophageal cancer	1.43e-05	5.01e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MYC—esophageal cancer	1.43e-05	5e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CREBBP—esophageal cancer	1.42e-05	4.98e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MYC—esophageal cancer	1.4e-05	4.92e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—EGFR—esophageal cancer	1.4e-05	4.89e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TP53—esophageal cancer	1.38e-05	4.85e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PIK3CA—esophageal cancer	1.38e-05	4.84e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTGS2—esophageal cancer	1.37e-05	4.82e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—EGFR—esophageal cancer	1.37e-05	4.81e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PIK3CA—esophageal cancer	1.37e-05	4.81e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PIK3CA—esophageal cancer	1.34e-05	4.68e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TP53—esophageal cancer	1.34e-05	4.68e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TP53—esophageal cancer	1.33e-05	4.65e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PIK3CA—esophageal cancer	1.3e-05	4.55e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TP53—esophageal cancer	1.29e-05	4.53e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MYC—esophageal cancer	1.28e-05	4.48e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—NOS3—esophageal cancer	1.27e-05	4.46e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—EGFR—esophageal cancer	1.25e-05	4.38e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PIK3CA—esophageal cancer	1.21e-05	4.25e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PIK3CA—esophageal cancer	1.19e-05	4.18e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TP53—esophageal cancer	1.17e-05	4.11e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTGS2—esophageal cancer	1.16e-05	4.08e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TP53—esophageal cancer	1.15e-05	4.04e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—EP300—esophageal cancer	1.14e-05	4e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.1e-05	3.84e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CA—esophageal cancer	1.08e-05	3.8e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TP53—esophageal cancer	1.05e-05	3.68e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—NOS3—esophageal cancer	9.82e-06	3.44e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—EP300—esophageal cancer	9.68e-06	3.39e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTGS2—esophageal cancer	8.98e-06	3.15e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CA—esophageal cancer	8.45e-06	2.96e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—EP300—esophageal cancer	7.47e-06	2.62e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CA—esophageal cancer	7.16e-06	2.51e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CA—esophageal cancer	5.53e-06	1.94e-05	CbGpPWpGaD
